Akebia Therapeutics to Present at the Jefferies London Healthcare Conference

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA) has announced its participation in the upcoming Jefferies London Healthcare Conference. CEO John Butler will deliver a presentation on Thursday, November 21 at 1:00 PM GMT. The conference is scheduled for November 19-21, 2024, in London. Interested parties can access the presentation webcast through the 'Investors' section of Akebia's website at ir.akebia.com, where it will remain available for 30 days after the event. Akebia Therapeutics focuses on improving the lives of people affected by kidney disease.

News Market Reaction – AKBA

-2.01%

-2.01% Session move

In the trading session that priced this news, AKBA declined 2.01%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Nov. 12, 2024 /PRNewswire/ -- Akebia Therapeutics^®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the Jefferies London Healthcare Conference on Thursday, November 21 at 1:00 PM GMT.

A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 30 days following the conference.

The Jefferies London Healthcare Conference will take place November 19-21, 2024 in London.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-jefferies-london-healthcare-conference-302301773.html

SOURCE Akebia Therapeutics, Inc.

FAQ

When is Akebia Therapeutics (AKBA) presenting at the Jefferies London Healthcare Conference 2024?

Akebia Therapeutics (AKBA) will present on Thursday, November 21, 2024, at 1:00 PM GMT.

How long will the AKBA Jefferies Conference presentation webcast be available?

The webcast will be available for 30 days following the conference through Akebia's investor relations website.

What dates is the Jefferies London Healthcare Conference 2024 being held?

The Jefferies London Healthcare Conference will take place from November 19-21, 2024, in London.

Where can I watch Akebia Therapeutics' (AKBA) Jefferies Conference presentation?

The presentation can be accessed through the 'Investors' section of Akebia's website at ir.akebia.com.